HEADER TRANSFERASE/TRANSFERASE INHIBITOR 24-MAR-11 3R8Z TITLE CDK2 IN COMPLEX WITH INHIBITOR RC-1-136 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLIN-DEPENDENT KINASE 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CDK2, CELL DIVISION PROTEIN KINASE 2, P33 PROTEIN KINASE; COMPND 5 EC: 2.7.11.22; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CDK2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: TUNER(DE); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX6P-1 KEYWDS PROTEIN KINASE, INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.BETZI,R.ALAM,H.HAN,A.BECKER,E.SCHONBRUNN REVDAT 4 13-SEP-23 3R8Z 1 REMARK SEQADV REVDAT 3 05-JUN-13 3R8Z 1 JRNL REVDAT 2 15-MAY-13 3R8Z 1 JRNL REVDAT 1 31-OCT-12 3R8Z 0 JRNL AUTH E.SCHONBRUNN,S.BETZI,R.ALAM,M.P.MARTIN,A.BECKER,H.HAN, JRNL AUTH 2 R.FRANCIS,R.CHAKRASALI,S.JAKKARAJ,A.KAZI,S.M.SEBTI, JRNL AUTH 3 C.L.CUBITT,A.W.GEBHARD,L.A.HAZLEHURST,J.S.TASH,G.I.GEORG JRNL TITL DEVELOPMENT OF HIGHLY POTENT AND SELECTIVE DIAMINOTHIAZOLE JRNL TITL 2 INHIBITORS OF CYCLIN-DEPENDENT KINASES. JRNL REF J.MED.CHEM. V. 56 3768 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 23600925 JRNL DOI 10.1021/JM301234K REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.78 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1427540.040 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 23236 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1162 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.85 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.97 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3612 REMARK 3 BIN R VALUE (WORKING SET) : 0.2380 REMARK 3 BIN FREE R VALUE : 0.2760 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 190 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.020 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2329 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 18 REMARK 3 SOLVENT ATOMS : 141 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.74000 REMARK 3 B22 (A**2) : -4.51000 REMARK 3 B33 (A**2) : 3.77000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM SIGMAA (A) : 0.14 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.18 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.950 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.270 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.160 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.570 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.340 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.40 REMARK 3 BSOL : 47.81 REMARK 3 REMARK 3 NCS MODEL : NONE REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : R36.PAR REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : R36.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 3R8Z COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-MAR-11. REMARK 100 THE DEPOSITION ID IS D_1000064639. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-FEB-08 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944+ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23236 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.03700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.58 REMARK 200 R MERGE FOR SHELL (I) : 0.20300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.390 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS 1.2 REMARK 200 STARTING MODEL: PDB ENTRY 1PW2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.68 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.94 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 5 MG/ML CDK2 PROTEIN, 3 MM INHIBITOR, REMARK 280 15% V/V PEG3350, 50 MM HEPES/NAOH, 50 MM NA/K PHOSPHATE , PH 7.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.55000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 35.64000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.68000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 35.64000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.55000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.68000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -7 REMARK 465 PRO A -6 REMARK 465 LEU A -5 REMARK 465 GLY A -4 REMARK 465 SER A -3 REMARK 465 PRO A -2 REMARK 465 GLU A -1 REMARK 465 PHE A 0 REMARK 465 LEU A 37 REMARK 465 ASP A 38 REMARK 465 THR A 39 REMARK 465 GLU A 40 REMARK 465 VAL A 156 REMARK 465 ARG A 157 REMARK 465 THR A 158 REMARK 465 TYR A 159 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 6 96.12 -65.28 REMARK 500 GLU A 42 -8.02 -172.12 REMARK 500 VAL A 44 105.06 57.69 REMARK 500 ARG A 126 -20.60 81.72 REMARK 500 LEU A 148 40.88 29.10 REMARK 500 PHE A 152 -68.26 -123.93 REMARK 500 HIS A 161 57.21 39.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE Z63 A 440 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3QL8 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR JWS-6-260 REMARK 900 RELATED ID: 3QQF RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR L1 REMARK 900 RELATED ID: 3QQG RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR L2-5 REMARK 900 RELATED ID: 3QQH RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR L2-2 REMARK 900 RELATED ID: 3QQJ RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR L2 REMARK 900 RELATED ID: 3QQK RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR L4 REMARK 900 RELATED ID: 3QQL RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR L3 REMARK 900 RELATED ID: 3QRT RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR NSK-MC2-55 REMARK 900 RELATED ID: 3QRU RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR NSK-MC1-12 REMARK 900 RELATED ID: 3QTQ RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-1-137 REMARK 900 RELATED ID: 3QTR RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-1-148 REMARK 900 RELATED ID: 3QTS RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-12 REMARK 900 RELATED ID: 3QTU RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-132 REMARK 900 RELATED ID: 3QTW RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-13 REMARK 900 RELATED ID: 3QTX RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-35 REMARK 900 RELATED ID: 3QTZ RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-36 REMARK 900 RELATED ID: 3QU0 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-38 REMARK 900 RELATED ID: 3QWJ RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-142 REMARK 900 RELATED ID: 3QWK RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-150 REMARK 900 RELATED ID: 3QX2 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-190 REMARK 900 RELATED ID: 3QX4 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-78 REMARK 900 RELATED ID: 3QXO RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-84 REMARK 900 RELATED ID: 3QXP RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-3-89 REMARK 900 RELATED ID: 3QZF RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR JWS-6-52 REMARK 900 RELATED ID: 3QZG RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR JWS-6-76 REMARK 900 RELATED ID: 3QZH RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-124 REMARK 900 RELATED ID: 3QZI RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-126 REMARK 900 RELATED ID: 3R1Q RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-102 REMARK 900 RELATED ID: 3R1S RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-127 REMARK 900 RELATED ID: 3R1Y RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-134 REMARK 900 RELATED ID: 3R28 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-140 REMARK 900 RELATED ID: 3R6X RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-158 REMARK 900 RELATED ID: 3R71 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-162 REMARK 900 RELATED ID: 3R73 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-164 REMARK 900 RELATED ID: 3R7E RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-67 REMARK 900 RELATED ID: 3R7I RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-74 REMARK 900 RELATED ID: 3R7U RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-75 REMARK 900 RELATED ID: 3R7V RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-9 REMARK 900 RELATED ID: 3R7Y RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-2-88 REMARK 900 RELATED ID: 3R83 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-2-92 REMARK 900 RELATED ID: 3R8L RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR L3-4 REMARK 900 RELATED ID: 3R8M RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR L3-3 REMARK 900 RELATED ID: 3R8P RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR NSK-MC1-6 REMARK 900 RELATED ID: 3R8U RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-1-132 REMARK 900 RELATED ID: 3R8V RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-1-135 REMARK 900 RELATED ID: 3R9D RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-135 REMARK 900 RELATED ID: 3R9H RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-142 REMARK 900 RELATED ID: 3R9N RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-21 REMARK 900 RELATED ID: 3R9O RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-143 REMARK 900 RELATED ID: 3RAH RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-22 REMARK 900 RELATED ID: 3RAI RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-160 REMARK 900 RELATED ID: 3RAK RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-32 REMARK 900 RELATED ID: 3RAL RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-34 REMARK 900 RELATED ID: 3RJC RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR L4-12 REMARK 900 RELATED ID: 3RK5 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-72 REMARK 900 RELATED ID: 3RK7 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-71 REMARK 900 RELATED ID: 3RK9 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-74 REMARK 900 RELATED ID: 3RKB RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-73 REMARK 900 RELATED ID: 3RM6 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-2-80 REMARK 900 RELATED ID: 3RM7 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-91 REMARK 900 RELATED ID: 3RMF RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-33 REMARK 900 RELATED ID: 3RNI RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-3-86 REMARK 900 RELATED ID: 3ROY RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-154 REMARK 900 RELATED ID: 3RPO RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-156 REMARK 900 RELATED ID: 3RPR RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-49 REMARK 900 RELATED ID: 3RPV RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-88 REMARK 900 RELATED ID: 3RPY RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-40 REMARK 900 RELATED ID: 3RZB RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-23 REMARK 900 RELATED ID: 3S00 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR L4-14 REMARK 900 RELATED ID: 3S0O RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-1-138 REMARK 900 RELATED ID: 3S1H RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-39 REMARK 900 RELATED ID: 3SQQ RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-3-96 DBREF 3R8Z A 1 298 UNP P24941 CDK2_HUMAN 1 298 SEQADV 3R8Z GLY A -7 UNP P24941 EXPRESSION TAG SEQADV 3R8Z PRO A -6 UNP P24941 EXPRESSION TAG SEQADV 3R8Z LEU A -5 UNP P24941 EXPRESSION TAG SEQADV 3R8Z GLY A -4 UNP P24941 EXPRESSION TAG SEQADV 3R8Z SER A -3 UNP P24941 EXPRESSION TAG SEQADV 3R8Z PRO A -2 UNP P24941 EXPRESSION TAG SEQADV 3R8Z GLU A -1 UNP P24941 EXPRESSION TAG SEQADV 3R8Z PHE A 0 UNP P24941 EXPRESSION TAG SEQRES 1 A 306 GLY PRO LEU GLY SER PRO GLU PHE MET GLU ASN PHE GLN SEQRES 2 A 306 LYS VAL GLU LYS ILE GLY GLU GLY THR TYR GLY VAL VAL SEQRES 3 A 306 TYR LYS ALA ARG ASN LYS LEU THR GLY GLU VAL VAL ALA SEQRES 4 A 306 LEU LYS LYS ILE ARG LEU ASP THR GLU THR GLU GLY VAL SEQRES 5 A 306 PRO SER THR ALA ILE ARG GLU ILE SER LEU LEU LYS GLU SEQRES 6 A 306 LEU ASN HIS PRO ASN ILE VAL LYS LEU LEU ASP VAL ILE SEQRES 7 A 306 HIS THR GLU ASN LYS LEU TYR LEU VAL PHE GLU PHE LEU SEQRES 8 A 306 HIS GLN ASP LEU LYS LYS PHE MET ASP ALA SER ALA LEU SEQRES 9 A 306 THR GLY ILE PRO LEU PRO LEU ILE LYS SER TYR LEU PHE SEQRES 10 A 306 GLN LEU LEU GLN GLY LEU ALA PHE CYS HIS SER HIS ARG SEQRES 11 A 306 VAL LEU HIS ARG ASP LEU LYS PRO GLN ASN LEU LEU ILE SEQRES 12 A 306 ASN THR GLU GLY ALA ILE LYS LEU ALA ASP PHE GLY LEU SEQRES 13 A 306 ALA ARG ALA PHE GLY VAL PRO VAL ARG THR TYR THR HIS SEQRES 14 A 306 GLU VAL VAL THR LEU TRP TYR ARG ALA PRO GLU ILE LEU SEQRES 15 A 306 LEU GLY CYS LYS TYR TYR SER THR ALA VAL ASP ILE TRP SEQRES 16 A 306 SER LEU GLY CYS ILE PHE ALA GLU MET VAL THR ARG ARG SEQRES 17 A 306 ALA LEU PHE PRO GLY ASP SER GLU ILE ASP GLN LEU PHE SEQRES 18 A 306 ARG ILE PHE ARG THR LEU GLY THR PRO ASP GLU VAL VAL SEQRES 19 A 306 TRP PRO GLY VAL THR SER MET PRO ASP TYR LYS PRO SER SEQRES 20 A 306 PHE PRO LYS TRP ALA ARG GLN ASP PHE SER LYS VAL VAL SEQRES 21 A 306 PRO PRO LEU ASP GLU ASP GLY ARG SER LEU LEU SER GLN SEQRES 22 A 306 MET LEU HIS TYR ASP PRO ASN LYS ARG ILE SER ALA LYS SEQRES 23 A 306 ALA ALA LEU ALA HIS PRO PHE PHE GLN ASP VAL THR LYS SEQRES 24 A 306 PRO VAL PRO HIS LEU ARG LEU HET Z63 A 440 18 HETNAM Z63 [4-AMINO-2-(PROP-2-EN-1-YLAMINO)-1,3-THIAZOL-5- HETNAM 2 Z63 YL](PYRIDIN-4-YL)METHANONE FORMUL 2 Z63 C12 H12 N4 O S FORMUL 3 HOH *141(H2 O) HELIX 1 1 PRO A 45 LYS A 56 1 12 HELIX 2 2 LEU A 87 SER A 94 1 8 HELIX 3 3 PRO A 100 HIS A 121 1 22 HELIX 4 4 LYS A 129 GLN A 131 5 3 HELIX 5 5 ALA A 170 LEU A 175 1 6 HELIX 6 6 THR A 182 ARG A 199 1 18 HELIX 7 7 SER A 207 GLY A 220 1 14 HELIX 8 8 GLY A 229 MET A 233 5 5 HELIX 9 9 ASP A 247 VAL A 251 5 5 HELIX 10 10 ASP A 256 LEU A 267 1 12 HELIX 11 11 SER A 276 ALA A 282 1 7 HELIX 12 12 HIS A 283 GLN A 287 5 5 SHEET 1 A 5 PHE A 4 GLU A 12 0 SHEET 2 A 5 GLY A 16 ASN A 23 -1 O LYS A 20 N GLU A 8 SHEET 3 A 5 VAL A 29 ILE A 35 -1 O LEU A 32 N TYR A 19 SHEET 4 A 5 LYS A 75 GLU A 81 -1 O LEU A 78 N LYS A 33 SHEET 5 A 5 LEU A 66 THR A 72 -1 N ILE A 70 O TYR A 77 SHEET 1 B 3 GLN A 85 ASP A 86 0 SHEET 2 B 3 LEU A 133 ILE A 135 -1 O ILE A 135 N GLN A 85 SHEET 3 B 3 ILE A 141 LEU A 143 -1 O LYS A 142 N LEU A 134 CISPEP 1 PRO A 253 PRO A 254 0 0.32 SITE 1 AC1 11 VAL A 18 ALA A 31 VAL A 64 GLU A 81 SITE 2 AC1 11 PHE A 82 LEU A 83 ASP A 86 LEU A 134 SITE 3 AC1 11 ASP A 145 HOH A 410 HOH A 433 CRYST1 53.100 71.360 71.280 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018832 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014013 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014029 0.00000